<PAGE> 1
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
---------------
FORM 10-Q/A
(Mark One)
/X/ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 1996
OR
/ / TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
For the transition period from to
Commission file number 0-22890
SANGSTAT MEDICAL CORPORATION
(Exact name of registrant as specified in its charter)
DELAWARE 94-3076-069
(State or other jurisdiction of (I.R.S. Employer
incorporation or organization) Identification No.)
1505 ADAMS DRIVE, MENLO PARK CA 94025
(Address of principal executive offices and zip code)
(415) 328-0300
(Registrant's telephone number, including area code)
None
Former Name, Former Address and Former Fiscal Year, if Changed Since Last
Report.
Indicate by check [X] whether the registrant (1) has filed all reports
required to be filed by Sections 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days. Yes X No
--- ---
The number of shares outstanding of each of the issuer's classes of common stock
as of:
<TABLE>
<CAPTION>
Class Outstanding at June 30, 1996
- ------------ ----------------------------
<S> <C>
Common Stock 13,078,983
</TABLE>
<PAGE> 2
ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K
(a) Exhibits
10.24* Amended and Restated Collaborative Agreement
(b) There were no reports on Form 8-K filed during the period
covered by this report.
*Specified portions of this agreement have been omitted and have been filed
separately with the Commission pursuant to a request for confidential treatment.
2
<PAGE> 3
SIGNATURES
PURSUANT TO THE REQUIREMENTS OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED,
THE REGISTRANT HAS DULY CAUSED THIS REPORT TO BE SIGNED IN ITS BEHALF BY THE
UNDERSIGNED THEREUNTO DULY AUTHORIZED.
SANGSTAT MEDICAL CORPORATION
(REGISTRANT)
DATED: November 27, 1996 By: /s/ DAVID L. WINTER, M.D.
------------------------------------------
President and Chief Operating Officer
DATED: November 27, 1996 By: /s/ HENRY N. EDMUNDS, PH.D.
------------------------------------------
Vice President and Chief Financial Officer
3
<PAGE> 4
EXHIBIT INDEX
10.24* Amended and Restated Collaborative Agreement
- ---------------------
* Specified portions of this agreement have been omitted and have been filed
separately with the Commission pursuant to a request for confidential treatment.
